Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bank of America identifies AstraZeneca, Bayer and Roche as its primary pharmaceutical recommendations, emphasizing pipeline upside and compelling valuation. Genmab is singled out as the high-conviction SMID biotech pick ahead of multiple Phase III readouts. Novartis remains rated Buy despite strong year-to-date performance.
Can-Fite BioPharma announced Q2 2026 financial results alongside key clinical progress. The pivotal Phase III study in liver cancer showed longer-than-expected overall survival while maintaining a blinded status, prompting consideration for an earlier interim analysis. Positive durable survival outcomes were also observed in a Phase IIa pancreatic …
Veru Inc. announced positive preclinical data showing oral sabizabulin's potent anticancer activity against KRAS-driven metastatic pancreatic cancer cell lines resistant to FDA-approved daraxonrasib. Based on these results and prior clinical safety and efficacy data, the company plans to initiate a Phase 2b clinical trial for sabizabulin in patient…
Intellia Therapeutics (NTLA) saw an 8% share increase after the FDA accepted its Biologics License Application with Priority Review for lonvoguran ziclumeran (lonvo-z) to treat hereditary angioedema. The agency set a target action date of March 10, 2027 and indicated it does not currently plan to convene an advisory committee. The BLA is supported …
IonQ's stock rose in pre-market trading after the company raised its full-year 2026 revenue guidance to $450 million to $460 million, reflecting the addition of SkyWater Technology after the $1.8 billion acquisition closed on July 31, 2026. The revised outlook incorporates SkyWater's results from the acquisition date through December 31, 2026 and r…
GRI Bio, Inc. announced new comprehensive Phase 2a clinical data for its oral drug candidate GRI-0621 in idiopathic pulmonary fibrosis (IPF). The study highlights nine mechanistic pillars supporting GRI-0621's action, including immune modulation, anti-fibrotic effects, basement membrane repair, and alveolar epithelial regeneration. Results also sho…
Worthington Enterprises Inc. (NYSE: WOR) announced its fiscal first quarter 2027 earnings call scheduled for September 23, 2026. The company will release its quarterly financial results after market close on September 22, followed by a live webcast conference call. Worthington Enterprises operates in building products and consumer products sectors …
Yemen’s Houthi movement, backed by Iran, has resumed missile and drone strikes on Saudi cities, energy infrastructure and Red Sea shipping. The escalation, which comes more than six months into the U.S. war with Iran, risks re-igniting Yemen’s frozen civil war and further disrupting global trade and oil exports already strained by disruptions in th…
Amazon has engaged banks to arrange its first-ever bond sale denominated in British pounds, targeting four maturities and signaling continued cross-currency borrowing by large cloud and internet companies to support AI-related capital needs. The size of the planned offering was not disclosed and timing is subject to market conditions.
Phillips Edison & Company, Inc., a leading owner and operator of grocery-anchored shopping centers, announced that its CFO John Caulfield will participate in the Retail REIT Panel at the Barclays 24th Annual Global Financial Services Conference on September 14, 2026. The event will be webcast and a replay will be available on the company's investor…
Air France-KLM ADS (AFLYY) trades at a compelling valuation - market cap roughly $3.45B and a trailing PE near 2.8 - but near-term visibility is poor. Geopolitical disruptions, integration risk from the planned SAS takeover, and seasonal/fuel dynamics make the stock a neutral play. We outline a tactical long with clear entry, stop and target for tr…
Jefferies has named five preferred stocks in the technology, media and telecommunications sector after the August 2026 reporting season, focusing on firms that exhibit robust balance sheets and clear pricing power amid uncertain economic conditions. The broker singled out Carsales.com, REA Group, Megaport, Infratil and Life360, noting valuation and…
Shares of Sweetgreen climbed in pre-market trading after KeyBanc upgraded the fast-casual chain from Sector Weight to Overweight and set a $9.00 price target. The bank substantially raised its same-store sales and profitability forecasts for 2026 and 2027, citing signs that traffic and sales trends have stabilized, a view that traders interpreted a…
Developers working in the Beetaloo Basin have brought in U.S. equipment, financing and operational practices with the goal of lowering costs enough to make Australia’s first commercial shale gas development viable. The remote Northern Territory site produced its first gas this month, but developers say substantial cost reductions, pipeline investme…
AMD is positioned to capture accelerating AI and datacenter spending through competitive CPU and GPU stacks plus FPGA/SoC integration. This trade idea recommends a long entry at $120.00 with a $200.00 target and a $95.00 stop, tailored for a long-term horizon (180 trading days). Key catalysts include next-gen accelerator ramps, enterprise CPU share…
FTC Solar has commenced shipments for the 330 MW Fraser Coast solar and 180 MW battery storage project in Queensland, Australia. Developed by Global Power Generation (GPG), this represents Naturgy's largest renewable energy investment in Australia. FTC Solar's innovative terrain-following tracker technology will reduce installation costs and enviro…
Upexi, Inc., a NASDAQ-listed digital asset treasury company focused on Solana cryptocurrency and consumer brand ownership, announced that its Chief Strategy Officer, Brian Rudick, will attend the FT Partners FinTech Conference 2026 in New York to hold investor meetings. The company emphasizes its disciplined approach to acquiring and managing Solan…
Spyre Therapeutics announced positive 12-week induction results from Part A of its Phase 2 SKYLINE trial evaluating SPY003, an anti-IL-23 antibody for moderately-to-severely active ulcerative colitis. SPY003 met its primary endpoint with a highly statistically significant reduction in Robart's Histopathology Index score and showed favorable clinica…
PMV Pharmaceuticals has appointed Philip Herman as Chief Commercial Officer to spearhead commercial strategy and launch preparations for rezatapopt, its first-in-class p53 reactivator for platinum-resistant/refractory ovarian cancer. The company plans to submit a New Drug Application for accelerated approval of rezatapopt in the first quarter of 20…
Enphase Energy announced that its power modules for the IQ Solid-State Transformer, designed specifically for AI data centers requiring 800 VDC power architectures, are now being manufactured in Texas. The modular IQ SST system converts medium-voltage AC to high-voltage DC with rapid response times, aiming to reduce local battery use. The company p…
Avalyn Pharma presented new data at the ERS Congress 2026 demonstrating the effective lung distribution of its inhaled antifibrotic therapy AP01 across varying severities of pulmonary fibrosis, supported by in silico modeling. Additionally, patient survey data emphasized the importance of clear communication and reducing logistical burdens to enhan…
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on oral delivery of biologics, announced that its management team will participate in several investment conferences in September 2026, including the BIG10 Conference and the H.C. Wainwright Global Investment Conference. The company will present its latest developments and…
Aduro Clean Technologies (NASDAQ: ADUR) announced that Chief Revenue Officer Eric Appelman will present their Hydrochemolytic™ Technology (HCT) for chemical recycling of polyolefins at the Chemical Recycling Europe Annual Conference 2026. Aduro is advancing HCT from pilot-scale validation toward industrial deployment, including a First-of-a-Kind (F…
Structure Therapeutics announced positive clinical trial results for two oral small molecule candidates targeting chronic weight management: ACCG-2671 (oral amylin receptor agonist) demonstrated a 6-day half-life and up to 3.3% body weight reduction in Phase 1/2a trial; aleniglipron (oral GLP-1 receptor agonist) showed up to 16.2% mean body weight …
Intellia Therapeutics announced that the FDA has accepted its Biologics License Application (BLA) for lonvoguran ziclumeran (lonvo-z), the world's first in vivo CRISPR-based therapy and a potential one-time treatment for hereditary angioedema (HAE). The FDA has granted Priority Review with a PDUFA date of March 10, 2027, signaling a potentially exp…
